Why Is MiNK Therapeutics Stock Trading Lower On Wednesday?

MiNK Therapeutics Inc. (NASDAQ:INKT) shares are down during Wednesday’s premarket session, possibly on profit-taking after the stock rallied roughly 30% on Tuesday.On Tuesday, the company announced a strategic collaboration aimed at developing a PRAME-targeted TCR-engineered iNKT cell therapy for pediatric cancers.$1.1 Million Funding for MiNK Therapeutics PRAME-TCR-iNKT AssetUnder the collaboration, MiNK Therapeutics will receive approximately $1.1 million in non-dilutive funding to support the development ...